Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.
PloS one, vol.9, no.11, 2014 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 9 Issue: 11
- Publication Date: 2014
- Doi Number: 10.1371/journal.pone.0113597
- Journal Name: PloS one
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Akdeniz University Affiliated: Yes
Abstract
Purpose: We have compared cure from local/metastatic tumor growth in BALB/c mice receiving EMT6 or the poorly immunogenic, highly metastatic 4THM, breast cancer cells following manipulation of immunosuppressive CD200:CD200R interactions or conventional chemotherapy.